These medications are tools for managing certain health conditions, not general fat loss strategies
For patients with type 2 diabetes, the American Diabetes Association (ADA) Standards of Care emphasize individualized glycemic targets and treatment selection based on patient-specific factors including baseline hemoglobin A1c (HbA1c), presence of atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease, hypoglycemia risk, weight considerations, and patient preferences
Prospective cohort studies have shown that increased plasma TMAO levels predicted an elevated risk of MACE in patients with pre-existing AS ( Table 1 )
Regular Check-Ins: Regular check-ins with your healthcare provider and coach help monitor your progress and make any necessary adjustments to your treatment plan
Published 2023 May 25
Change is on the horizon, though